BioSpace News Archive

New features for intuitive biomarker classification and improved usability

Panel to feature discussions about current experiences in microbiome drug development and the promising future of microbiome therapies

Turnstone Biologics announced that Sammy Farah, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Recro Pharma, Inc. and certain of its officers, on behalf of shareholders who purchased Recro securities between July 31, 2017 through May 23, 2018.

Endoscopic Device Uses Extreme Cold to Eradicate Precancerous Lesions and Minimize Post-Procedural Pain in 30-Minute Procedure

Oncternal Therapeutics, Inc., today announced that data from a Phase 1 clinical trial of humanized IgG1 monoclonal antibody, cirmtuzumab.

Here are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

Warriors and supporters were honored at the Wounded Warrior Project® (WWP) Courage Awards & Benefit Dinner® at Gotham Hall.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in June 2018.

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT® (baricitinib), a once-daily oral medication for the treatment of adults with moderately-to-severely active rheumatoid arthritis (RA).